News 09 fev 2023 Japanese GC Group now being managed from Lucerne The GC Group, a specialist in the area of dental products, is moving the heart of the business from its previous headquarters in Tokyo to Lucerne...
News 07 jun 2023 Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site in South K...
Spotlight 15 jun 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Webinar 11 nov 2020 How to enter the Japanese medtech market Japan is the fastest aging society. Its medical device market with an average growth rate of approx. 5% is therefore an interesting export target...
Success stories 25 mai 2023 Yokogawa Innovation Switzerland: How microalgae open up new possibilities for food and medicine. Yokogawa Electric Corporation Microalgae open up new possibilities for food and medicine. From its base in Switzerland, the mission of YIS is to find promising biotechnology f...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 21 jun 2022 Takeda to invest CHF 200 million in its Neuchâtel production site Japanese pharmaceutical group Takeda will be expanding its production site in Pierre-à-Bot and build a new aseptic filling line, an investment of...
Success stories 31 jan 2023 BÜCHI Labortechnik: Consistent go-to-market strategy BÜCHI generates 97% of its turnover abroad. With 20 subsidiaries and numerous sales partners on all continents, the company is consistently pursu...
News 26 out 2022 Sumitovant acquires all shares in Myovant Sumitovant is in the process of making Myovant a wholly owned subsidiary by acquiring a 100 percent shareholding in the company for 27 dollars pe...
News 09 fev 2022 ADC Therapeutics secures USD 30 million in new partnership deal ADC Therapeutics’ new partnership will focus on the development and commercialization of ZYNLONTA in Japan, for which the Vaud-based company will...
News 04 nov 2021 INTEGRA Biosciences builds campus in Graubünden The laboratory equipment specialist INTEGRA Biosciences AG is expanding its headquarters in Zizers in the Greater Zurich Area. It plans to build ...